CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $37,943
- in 1 filing
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-02 | HENSON HEIDI Director | Grant or award · Stock Options (right to buy) | +230,000 | 700,000 | ||
| 2023-04-17 | Woods Lori A Director | Option exercise | +23,566 | $0.61 | $14K | 1,334,538 |
| 2023-04-17 | Woods Lori A Director | Option exercise · Stock Options (right to buy) | −23,566 | 0 | ||
| 2023-04-13 | Woods Lori A Director | Option exercise | +163,934 | $0.61 | $100K | 1,310,972 |
| 2023-04-13 | Woods Lori A Director | Option exercise · Stock Options (right to buy) | −163,934 | 0 | ||
| 2023-02-21 | Williamson Robert F III Director | Grant or award · Stock Options (right to buy) | +470,000 | 470,000 | ||
| 2023-02-21 | Williamson Robert F III Director | Grant or award · Stock Options (right to buy) | +230,000 | 700,000 | ||
| 2023-02-21 | Morich Frank Director | Grant or award · Stock Options (right to buy) | +470,000 | 1,577,471 | ||
| 2023-02-21 | Morich Frank Director | Grant or award · Stock Options (right to buy) | +230,000 | 1,807,471 | ||
| 2023-02-21 | Woods Lori A Director | Grant or award · Stock Options (right to buy) | +470,000 | 2,140,000 | ||
| 2023-02-21 | Woods Lori A Director | Grant or award · Stock Options (right to buy) | +230,000 | 2,370,000 | ||
| 2023-02-21 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +470,000 | 894,615 | ||
| 2023-02-21 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +230,000 | 1,124,615 | ||
| 2022-12-05 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +32,200 | $0.38 | $12K | 191,710 |
| 2022-12-01 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +53,204 | $0.38 | $20K | 159,510 |
| 2022-11-15 | Woods Lori A CEO | Purchase | +100,000 | $0.34 | $34K | 1,147,038 |
| 2022-08-18 | Streeter Jennifer COO & VP of HR | Option exercise | +50,000 | $0.43 | $22K | 77,940 |
| 2022-08-18 | Streeter Jennifer COO & VP of HR | Option exercise · Stock Options (right to buy) | −50,000 | 0 | ||
| 2022-08-18 | Streeter Jennifer COO & VP of HR | Option exercise | +50,000 | $0.43 | $22K | 87,940 |
| 2022-08-18 | Streeter Jennifer COO & VP of HR | Option exercise · Stock Options (right to buy) | −50,000 | 0 |
Page 6 of 26 · 502 trades